Alveolar macrophage release of neutrophil chemoattractants such as CXCL8 is corticosteroid insensitive in COPD, potentially contributing to the lack of impact of ICS treatment in neutrophilic COPD [55]. Here, CXCL8 is linked to chronic obstructive pulmonary disease.